Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Ticker SymbolRPID
Company nameRapid Micro Biosystems Inc
IPO dateJul 15, 2021
CEOMr. Robert (Rob) Spignesi
Number of employees163
Security typeOrdinary Share
Fiscal year-endJul 15
Address25 Hartwell Avenue
CityLEXINGTON
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code02421
Phone19783493200
Websitehttps://www.rapidmicrobio.com/
Ticker SymbolRPID
IPO dateJul 15, 2021
CEOMr. Robert (Rob) Spignesi
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data